GAM Holding’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.29M | Buy |
10,008
+479
| +5% | +$109K | 0.15% | 140 |
|
|
2025
Q3 | $2.21M | Buy |
9,529
+1,727
| +22% | +$352K | 0.14% | 140 |
|
|
2025
Q2 | $1.45M | Buy |
7,802
+981
| +14% | +$182K | 0.1% | 147 |
|
|
2025
Q1 | $1.43M | Sell |
6,821
-1,812
| -21% | -$352K | 0.11% | 143 |
|
|
2024
Q4 | $1.53M | Buy |
+8,633
| New | +$1.59M | 0.11% | 123 |
|
|
2022
Q3 | – | Sell |
-19,239
| Closed | -$2.95M | – | 223 |
|
|
2022
Q2 | $2.95M | Hold |
19,239
| – | – | 0.2% | 118 |
|
|
2022
Q1 | $3.12M | Sell |
19,239
-9
| -0% | -$1.31K | 0.15% | 130 |
|
|
2021
Q4 | $2.61M | Hold |
19,248
| – | – | 0.12% | 156 |
|
|
2021
Q3 | $2.08M | Sell |
19,248
-3,060
| -14% | -$350K | 0.1% | 173 |
|
|
2021
Q2 | $2.51M | Sell |
22,308
-5,877
| -21% | -$662K | 0.11% | 182 |
|
|
2021
Q1 | $3.05M | Buy |
+28,185
| New | +$3.01M | 0.14% | 171 |
|
|
2020
Q4 | – | Sell |
-41,888
| Closed | -$3.67M | – | 269 |
|
|
2020
Q3 | $3.67M | Buy |
41,888
+320
| +0.8% | +$30.1K | 0.22% | 141 |
|
|
2020
Q2 | $4.08M | Sell |
41,568
-1,280
| -3% | -$113K | 0.25% | 117 |
|
|
2020
Q1 | $3.26M | Sell |
42,848
-18,840
| -31% | -$1.6M | 0.22% | 126 |
|
|
2019
Q4 | $5.46M | Sell |
61,688
-12,435
| -17% | -$1.03M | 0.26% | 117 |
|
|
2019
Q3 | $5.61M | Sell |
74,123
-7,910
| -10% | -$542K | 0.25% | 113 |
|
|
2019
Q2 | $5.97M | Buy |
82,033
+5,337
| +7% | +$419K | 0.23% | 110 |
|
|
2019
Q1 | $6.18M | Buy |
76,696
+5,172
| +7% | +$423K | 0.26% | 102 |
|
|
2018
Q4 | $6.59M | Sell |
71,524
-6,450
| -8% | -$567K | 0.33% | 82 |
|
|
2018
Q3 | $7.38M | Buy |
77,974
+35,887
| +85% | +$3.4M | 0.27% | 101 |
|
|
2018
Q2 | $3.9M | Buy |
42,087
+18,298
| +77% | +$1.79M | 0.14% | 178 |
|
|
2018
Q1 | $2.25M | Sell |
23,789
-24,564
| -51% | -$2.7M | 0.08% | 267 |
|
|
2017
Q4 | $4.68M | Buy |
48,353
+31,261
| +183% | +$2.95M | 0.14% | 181 |
|
|
2017
Q3 | $1.52M | Sell |
17,092
-225,644
| -93% | -$17.2M | 0.06% | 296 |
|
|
2017
Q2 | $17.6M | Buy |
242,736
+7,136
| +3% | +$480K | 0.26% | 101 |
|
|
2017
Q1 | $15.4M | Buy |
235,600
+45,617
| +24% | +$2.87M | 0.24% | 107 |
|
|
2016
Q4 | $11.9M | Sell |
189,983
-304
| -0.2% | -$18.6K | 0.21% | 128 |
|
|
2016
Q3 | $12M | Sell |
190,287
-8,639
| -4% | -$559K | 0.21% | 119 |
|
|
2016
Q2 | $12.3M | Sell |
198,926
-174,964
| -47% | -$10.7M | 0.19% | 135 |
|
|
2016
Q1 | $21.4M | Sell |
373,890
-13,434
| -3% | -$749K | 0.36% | 67 |
|
|
2015
Q4 | $22.9M | Buy |
387,324
+25,117
| +7% | +$1.45M | 0.36% | 67 |
|
|
2015
Q3 | $19.7M | Sell |
362,207
-52,006
| -13% | -$3.39M | 0.34% | 72 |
|
|
2015
Q2 | $27.8M | Buy |
414,213
+32,054
| +8% | +$2.09M | 0.4% | 57 |
|
|
2015
Q1 | $22.4M | Sell |
382,159
-39,816
| -9% | -$2.41M | 0.33% | 72 |
|
|
2014
Q4 | $27.6M | Buy |
421,975
+101,400
| +32% | +$6.39M | 0.41% | 57 |
|
|
2014
Q3 | $18.5M | Buy |
320,575
+34,791
| +12% | +$1.93M | 0.27% | 100 |
|
|
2014
Q2 | $16.1M | Buy |
285,784
+68,847
| +32% | +$3.61M | 0.24% | 115 |
|
|
2014
Q1 | $11.2M | Buy |
+216,937
| New | +$11M | 0.18% | 149 |
|
|
2013
Q4 | – | Sell |
-206,337
| Closed | -$9.23M | – | 886 |
|
|
2013
Q3 | $9.23M | Buy |
+206,337
| New | +$9.15M | 0.17% | 147 |
|
Other funds holding ABBV
GAM Holding's ABBV Position: Q4 2025 in Review
GAM Holding increased its AbbVie (ABBV) stake by 5% in Q4 2025, buying an estimated $109K and bringing the position to 10,008 shares worth $2.29M. The position accounts for 0.15% of the portfolio, ranked #140.
GAM Holding first reported a position in ABBV in Q3 2013 and has held it in 39 quarters since. The position peaked at $27.8M in Q2 2015. 4,148 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- GAM Holding held 10,008 shares of AbbVie worth $2.29M as of Q4 2025.
- GAM Holding bought 479 AbbVie shares in Q4 2025, an estimated $109K.
- AbbVie made up 0.15% of GAM Holding's portfolio in Q4 2025, its #140 holding.
- GAM Holding first reported a position in AbbVie in Q3 2013 and has held it in 39 quarters since.
- GAM Holding's AbbVie position peaked at $27.8M in Q2 2015.
- 4,148 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on GAM Holding's 13F filing for Q4 2025, filed 17 Feb 2026.